Send the following on WhatsApp
Continue to ChatLenalidomide in relapsed/refractory mantle cell lymphoma post-bortezomib: Subgroup analysis of the MCL-001 study - https://avesis.istanbul.edu.tr/yayin/5a968dfa-9276-4acd-b744-ab503e08e836/lenalidomide-in-relapsed-refractory-mantle-cell-lymphoma-post-bortezomib-subgroup-analysis-of-the-mcl-001-study